The association of vitamin D supplementation with the risk of cancer in postmenopausal women
Cancer Causes and Control, 12/17/2013Redaniel MT, et al.
There is inconclusive evidence on whether vitamin D therapy reduces cancer risk. The authors investigated the effect of vitamin D (±calcium) supplementation on the risk of breast, ovarian, uterine, colorectal, and lung cancer in women. They found little evidence that vitamin D (largely with calcium) supplementation is associated with decreased breast, lung, ovarian, and uterine cancer risk.
The authors conducted a case–control study using the UK Clinical Practice Research Datalink (CPRD); cases were women aged ≥55 years with a first diagnosis of either breast, colorectal, lung, ovarian, or uterine cancer between 2002 and 2009, with at least 5 years of CPRD follow-up prior to the date of diagnosis, and controls were women without cancer, frequency-matched to cases by year of birth, date of study entry, length of follow-up, and general practice.
The association of vitamin D supplementation with the odds of developing each cancer was determined using multivariable logistic regression, controlling for body mass index, smoking, alcohol, and deprivation.
Ninety-seven percent of women took vitamin D with a calcium supplement.
Exposure to three or more prescriptions of vitamin D was associated with a 17 % reduced odds (95 % CI 0.71–0.97) of breast cancer versus 1–2 prescriptions, but this effect disappeared when omitting women first exposed within a year of diagnosis (OR 1.0, 95 % CI 0.82–1.23).
Having more than 10 prescriptions of vitamin D was associated with a 17 % lower odds (95 % CI 0.65–1.06) of colorectal cancer, but the estimates are imprecise.
There was little evidence of associations of supplements with lung or gynecological cancers.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.